Skip to content

Imaging study of cardiovascular in patients with end-stage renal disease

Imaging study of cardiovascular in patients with end-stage renal disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DND-17012976
Enrollment
Unknown
Registered
2017-10-13
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease and healthy individuals

Interventions

myohemoglobin&#32
Gold Standard:The clinical outcome will be the reference standard. New York Heart Association(NYHA)functional classification
A history of heart disease and other systemic disease associated with cardiovascular damage were excluded.
Index test:the&#32
of&#32
and&#32
on&#32
CT&#32
MRI
injury(C-Reactive&#32

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with end stage renal disease

Exclusion criteria

Exclusion criteria: (1) unsuitability for magnetic resonance imaging (MRI) examination due to severe heart failure; (2) presence of other systemic diseases associated with cardiovascular damage; (3) contraindication for MRI due to the presence of cardiac pacemaker or defibrillators and other unsafe ferromagnetic objects; (4) claustrophobia; (5) severe arrhythmia;

Design outcomes

Primary

MeasureTime frame
Marker of myocardial injury;Image feature of Contrast CT;Image feature of Contrast-enhanced MRI;

Countries

China

Contacts

Public ContactZhenlin Li

West China Hospital, Sichuan University

lzlcd01@126.com+86 18980602130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026